WHO ICTRP trial
Chinese Medicine in combination with western medicine for the prevention of…
ChiCTR2000032847 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000032847 |
|---|---|
| Public title | Chinese Medicine in combination with western medicine for the prevention of relapse in patients with severe psoriasis |
| Scientific title | Chinese herbal medicine (Gu-Ben Hua-Yu-fang) in combination with ixekizumab for the prevention of relapse in patients with severe psoriasis |
| Primary sponsor | Guangdong Hospital of traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Psoriasis |
| Interventions | Case series:oral Chinese herbal medicine (Gu ben hua yu fang) in combination ixekizumab |
| Registration date | May 13, 2020 |
| Target size | Case series:10 |
| Secondary IDs | ChiMCTR2000003295 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: